In addition to the desired specificity and affinity for their respective therapeutic targets, antibodybased drugs must also demonstrate an ability to be manufactured and formulated at the concentrations needed for therapeutic application and to remain resistant to aggregation during storage to reduce the risk of induced immunogenicity. Improvements to the thermodynamic stability of the folded state of the protein are considered to be critical for decreasing the aggregation propensity of the protein. In this work, we have improved the biophysical properties of a number of human domain antibodies (dAbs) by identifying mutations which decrease the propensity for dAb selfaggregation without compromising the affinity for their respective target antigen. The mutations were identified by subjecting phage-displayed error-prone PCR-generated libraries to a variety of generic environmental conditions (temperature, pH and protease) followed by antigen capture, facilitating selection for improved thermodynamic stability of the protein. The results indicate that sufficient sequence diversity usually exists within the complementarity determining regions of dAbs to allow for mutations that lead to improvements to biophysical properties with full retention of parent lead biochemical and biological properties. Improved biophysical properties were often accompanied by higher apparent melting temperature values, while alternative selection pressures often identified similar features, suggesting generic nature of these mutations.
Introduction
Biotherapeutics form the fastest-expanding segment of the global drug market, initially driven by recombinant proteins, these have been followed by monoclonal antibodies (mAbs), global sales of which are forecast to grow from $44.6 billion in 2011 to $58 billion in 2016 (BCC-Research, 2012 ), a reflection on both their efficacy and their safety.
Increasingly, novel antibody formats (such as domain antibodies (dAbs), scFvs, diabodies or bispecific mAbs) are being investigated to achieve therapeutic effects beyond those attainable with mAbs (Beck et al., 2010) . Following an early focus solely on identifying antibodies with high affinity and efficacy (Geyer et al., 2012) , there is now an additional focus on their biophysical properties (solubility at high concentration, protease and aggregation resistance), to improve safety and allow large-scale manufacturing and storage over extended periods of time at high concentrations.
Unlike small molecule drugs, protein therapeutics are chemically heterogeneous macromolecules with molecular weights in the 5-150 kDa range. The properties of biotherapeutics critically depend on the integrity and stability of their three-dimensional structure, both in terms of retention of functional activity as well as biophysical characteristics, such as aggregation resistance over extended periods of time. The latter process has been identified as one of the key driving forces behind the enhanced immunogenicity of preparations of recombinant erytropoietin containing increased level of aggregates after extended storage (Macdougall et al., 2012) . dAbs are the smallest antigen binding fragments of IgG, consisting of either the variable heavy chain (V H ) or the variable light chain (V K ) domains (Ward et al., 1989) . While dAbs isolated from existing mAbs tend towards an increased propensity for aggregation, certain V H domain families (for example V H 3) are significantly more stable in monomeric state, approaching or exceeding the stability of camelidderived V H H domains (Ewert et al., 2002) .
Different approaches have been explored to improve the biophysical properties of antibody fragments including rational design to remove aggregation-sensitive sequence motifs or consensus design on the basis of sequence homology and selection from a randomized combinatorial library (Ewert et al., 2003a) . In the absence of detailed structural information about the lead dAbs, whose biophysical properties we wished to improve, we decided to use phage display selection from randomized combinatorial libraries. The libraries are subjected to selection rounds where contact with increasingly challenging environmental stress alternates with antigen-driven recovery steps, thus enriching the phage population for clones which encode dAbs that retain functional activity even after exposure to extremes of temperature, pH or the presence of proteolytic enzymes.
The previous studies described by Jespers et al. (2004) , Famm et al. (2008) , Kristensen and Winter (1998) and Sieber et al. (1998) , each applied different stress conditions to different dAbs (or in some cases even other protein scaffolds) thus making the results potentially molecule specific and difficult to compare. In this work, we therefore focus on applying a single stress condition ( protease treatment) to a number of different dAbs as well as a multitude of stress conditions (temperature, low pH and protease treatment) on a group of highly homologous dAbs to compare the effects they have on the enrichment of dAbs with advantageous biophysical properties. After applying the single stress condition ( protease treatment) to different dAbs, we were able in all cases to identify clones with increased protease resistance which often was accompanied by a higher apparent melting temperature. Similarly, most of the alternative stress conditions (temperature and low pH) also allowed identification of more stable dAb variants, although the spectrum of mutations responsible for the changes were only partially shared between different conditions. Our results indicate that there is sufficient redundancy within the dAb sequence, often even only within the complementarity determining regions (CDRs), to allow high affinity binding and specificity to be combined with improved biophysical properties such as aggregation and protease resistance. are five homologous V H dAbs which bind the membrane-proximal domain of human TNFR1. DOM1h-131-511 is a V H dAb which binds domain three of human TNFR1. DOM4-130-54 is a V K dAb which binds human IL-1RI, while DOM15-10 and DOM15-26-555 are V K and V H human VEGF binding dAbs, respectively. Genes encoding the lead dAbs described above were cloned into a Fd phage display vector in which the gene III signal peptide sequence is replaced with the GAS leader signal peptide and the trypsin cleavage site between the gene III and dAb sequence has been removed (Enever et al., 2008) .
Materials and methods

Lead clones
Phage library production and pre-selection
For library construction, random mutations were introduced in the sequence of the parental dAb molecules by error-prone PCR using the Mutazyme II DNA polymerase (Stratagene), biotinylated primers and 5-50 pg of template per 50 μl reaction. After digestion with SalI and NotI (all restriction enzymes from NEB), the inserts were purified from undigested products using streptavidin-coated beads and ligated into Fd phage vector (described earlier). TB1 Escherichia coli cells were transformed with the purified ligation mix and plated on tetracycline agar plates. Library repertoires of between 6 × 10 8 and 3 × 10 9 were produced and functionality as assessed by antigen binding in a monoclonal phage ELISA (according to published procedures (Ignatovich et al., 2012) ) was between 10 and 63%. dAb phage libraries were pre-selected on their respective biotinylated target antigens at the following concentrations: 1 nM human TNFR1, 1 nM human IL-1RI-Fc or 2 nM VEGF, to remove any clones that no longer bound antigen following randomization of the lead clone by errorprone PCR. Antigen molecules were biotinylated using EZ-Link Sulfo-NHS-LC-Biotin (Pierce, USA).
Phage display stress selections
Following one round of pre-selection, phage libraries were subjected to the stress conditions of protease, elevated temperature or low pH pretreatment. Conditions were optimized for each library to identify the condition that would result in an ∼3-log titer (10 9 -10 6 ) difference between stress treated and untreated phage after panning with no more than 2-fold loss of unselected phage infectivity. High temperature stress consisted of either incubation at between 50 and 65°C for 2-16 h (for selecting more slowly denaturing clones, 'kinetic selection') or at 80°C for 10 min (for selecting clones with reversible thermal denaturation). Protease stress consisted of incubation with trypsin at 10-100 μg/ml of enzyme for between 1 and 16 h at 37°C in phosphate buffered saline (PBS), after which 50 μl of 2× Complete Protease Inhibitors (Roche) was added to block any further proteolytic activity. Under low pH stress conditions, phage aliquots were diluted 10-fold into 420 μl of HNC buffer (5 mM HEPES, 5 mM NaCl, 100 mM citrate, pH 3.2) and incubated for between 0.5 and 16 h, followed by neutralization with 80 μl of 1 M of Tris buffer (Sigma). These treatments were followed by selection against antigen under standard conditions (Verheesen and Laeremans, 2012) with elution by low pH (0.1 M glycine pH 2.2) instead of trypsin. After glycine elution, the phage was recovered, titered and amplified for the next round of selection.
Expression and purification of dAbs
After two to three rounds of stress selection, the genes encoding enriched dAb sequences were subcloned as polyclonal selection outputs into a pUC-based ampicillin resistant vector, where expression of proteins is driven by the lac promoter. A GAS1 leader sequence ensures secretion of soluble dAb into the periplasm and culture supernatant of E. coli (de Wildt, 2005) . After transformation into E. coli, dAbs from individual colonies were inoculated into OnEx lactose-based auto induction media (Novagen) for protein expression at 37°C for 24 h. dAbs were screened in unpurified form in the culture supernatant of 96-well plates or in purified form from 50 ml culture supernatants. After capture on protein L (DOM4-130-54 and DOM15-10 variants) or protein A (DOM1h-131-511, DOM1h-574-156 and DOM15-26-555 variants) streamline resin (Amersham Biosciences), the resin was washed with 2 × PBS and then 10 mM Tris-HCl pH 8.0. dAbs were eluted with 0.1 M Glycine pH 2.2 and neutralized with 1 M Tris-HCl pH 8.0, following by buffer exchange to PBS.
In vitro assays of protein binding activity
To determine retention of functionality after protease treatment, 100-200 nM purified dAb (or bacterial supernatant containing dAb) was treated with 20-100 µg/ml trypsin (Sigma), 100 μg/ml leucozyme or 100 μg/ml elastase for 1 h, 3 h or overnight at 37°C, with or without agitation (250 rpm). Protease activity was blocked with Roche Complete Protease Inhibitor. Antigen binding of protease treated and untreated samples was then compared, using surface plasmon resonance (SPR) spectroscopy on a BIAcore 3000 Instrument (BIAcore, Uppsala, Sweden). Biotinylated human VEGF, human IL1 R-1-Fc and human TNFR1 were coupled to a Streptavidin (SA) Biacore chip. The dAb was diluted in HBS-EP running buffer and injected at a series of concentrations. Complex formation was observed at a continuous flow rate of 50 µl/ min. The sensorgrams were corrected by subtraction of the corresponding signals measured for the control blank channel and binding traces of protease treated and untreated samples compared. In order to obtain kinetic parameters, data were fitted to a 1:1 Langmuir binding model with the BIAevaluation software (Myszka, 1999) .
Size exclusion chromatography with multi-angle-LASER-light-scattering
Size exclusion chromatography (SEC) with multi-angle-LASER-lightscattering (MALLS) was used to characterize dAbs in solution. In brief, proteins at 1 mg/ml in buffer Dulbecco's PBS are separated according to their hydrodynamic properties by SEC (column: TSK3000 from TOSOH Biosciences; S200 from Pharmacia) at a flow rate of 0.5 ml/min. Following separation, the molecular weight of eluted species was measured using a MALLS detector (Wyatt Technologies) and analyzed using Astra v.5.3.4.12 software (Wyatt Technologies).
Differential scanning calorimetry
To determine the thermal stability of dAbs, differential scanning calorimetry (DSC) was used on a Microcal VP-DSC (GE Biosystems). In brief, the protein at a concentration of 1 mg/ml in PBS was heated at a constant rate of 180°C/h; temperature range was 20-85°C. Detectable heat change associated with thermal denaturation was measured. The apparent transition midpoint (apparent T m ) was determined, as most of the proteins examined do not fully refold, this is described as the temperature where 50% of the protein is in its native conformation and the other 50% is denatured. Unfolding curves were analyzed by non-2-state equations using OriginR v7.0383 software.
dAb accelerated aggregation assay
All proteins were buffer exchanged into PBS on PD10 columns and adjusted to a concentration of 1 mg/ml. Four aliquots of 250 µl each were prepared in 0.5 ml eppendorf test tubes and incubated for 0, 2, 23 and 47 h at 37°C followed by centrifugation at 16 100 × g for 10 min in microcentrifuge (Eppendorf, UK) before measuring A280 of each sample in M5e using a 96-well UV plate reader (Molecular Devices, USA) in order to determine the fraction of protein in solution. The fraction of protein in solution was calculated using the A280 value at 0 h as the reference solution.
Results
Identification of protease resistant variants of anti-TNF-R1, anti-IL-1R and anti-VEGF dAbs
Error-prone phage libraries of between 6 × 10 8 and 3 × 10 9 in size were created for each dAb by introducing mutations randomly across the whole dAb sequence with mutation rates of between 2.3 and 4.6 individual amino acid mutations per clone. Following a pre-selection round with each library (Round 1) of antigen binding in the absence of any protease treatment, phage output titers were in the 10 8 -10 10 range (compared with an input of 10 10 -10 11 phage) indicating that there were still a significant number of dAbs that bound antigen with high affinity. In the following rounds, protease treatment was introduced to select for dAbs of improved stability, with trypsin concentration and length of incubation varying between rounds to optimize the titer difference between the treated and untreated phage populations (Table I) . Following selection, dAb outputs were subcloned and selected for further characterization on the basis of sequence consensus and/or resistance to trypsin treatment in a supernatant binding assay. Clones chosen for further characterization were purified and then treated with trypsin (followed by neutralization of trypsin activity by Complete Protease Inhibitors) before measuring antigen binding by SPR on BIAcore. Lead clones from the four selections exhibited varying resistance to trypsin with the outputs from DOM4-130-54 and DOM15-26-555 selections achieving high stability with most remaining resistant to 100 μg/ml trypsin for 1 h and the best even after overnight incubation. Clones from the DOM15-10 and DOM1h-131-511 selections were less improved, but still had significantly increased protease resistance compared with the parental lead and were taken forward for further characterization. The clones selected for further analysis are shown in Fig 1. Clones DOM15-26-594 and DOM15-26-595 were created by mutagenesis to combine mutations that were enriched during selection (E6V and F100S/I).
Protease resistance of the lead dAbs
Lead molecules were chosen from each lineage and were compared with parent for their ability to bind their target antigen on the BIAcore at a dAb concentration of 500 nM (DOM1h and DOM4 variants) or 100 nM (DOM15 variant) after incubation with concentrations of trypsin (Sigma) ranging from 0 to 200 μg/ml either for 1 h or overnight at 37°C. The results clearly show that all lead dAbs are significantly more resistant to proteolysis than their parent clones indicating that the selection has been successful. The BIAcore traces for each lead molecule compared with parent are shown in Fig. 2 .
Some of the lead dAbs were also compared along with their parent clones against a range of other proteases including leucozyme and elastase and were found to show a general increase in resistance against all of them indicating that a general increase in protease resistance had been achieved during the selection rather than a trypsin specific effect obtained through the mutation of specific trypsin cleavage sites (Table II) .
Biophysical characterization of protease resistant variants of anti-TNFR1, anti-ILR-1 and anti-VEGF dAbs
The lead dAbs were further analyzed by SEC-MALLS and DSC in order to establish the oligomerization status of the lead clones and to measure the effective melting temperature (T m ), including estimating the fraction of reversibly folding dAb after a single cycle of heating and cooling. The majority of the selected DOM1, DOM4 and DOM15 variants showed higher apparent T m values (Table III) suggesting that increased trypsin stability may correlate with improved thermal stability. It is worth noting that both DOM15-26-555 and DOM15-10 parent molecules have much higher T m at the start (63.3 and 63.7°C, respectively) than the DOM4-130-54 and DOM1h-131-511 parent molecules (T m : 54.1 and 57.9°C, respectively), with the protease resistant clones all reaching a T m around 65°C. Surprisingly, the higher melting temperature of the DOM4 and DOM15-26 variants was accompanied by improved refolding after brief incubation at 85°C, from 30 to 90% for DOM4-130-202 and from 20 to 28% for DOM15-26-593. Despite a 7°C increase in T m of DOM1h-131-206 compared with DOM1h-131-511, both molecules completely failed to refold after being heated up to 85°C, hence this is a property that is not directly related to high T m .
The solution state of the parental dAbs and their trypsin resistant variants was investigated by SEC-MALLS. DOM1h-131-511, DOM4-130-54 and DOM15-10 are monomers in solution and their trypsin resistant variants maintained this monomeric profile. DOM15-26-555 has a complex SEC profile with at least four peaks of increasing molar mass, consistent with multimerization of the dAb, while it is protease resistant variant DOM15-26-593 has a much simpler profile with mainly monomeric or dimeric dAb, indicating that trypsin treatment had selected for dAbs that have a reduced propensity to self-associate (data not shown).
Improved trypsin resistance stability was not achieved at the expense of affinity or efficacy, because all of the lead molecules showed the same or improved binding activity (KD) by SPR on BIAcore and functional antagonistic activity (EC 50 ) in biological assays (see Table III ).
DOM1h-131-206 was also compared with its parent, DOM1h-131-511 in a number of accelerated stability assays comparing both the propensity to form multimers and the retention of functional activity after extended storage at 37°C. After storage in PBS for 7 days at 37°C, the amount of monomer in the sample had dropped from 95.7 to 62.7% for DOM1h-131511 but had only dropped from 99.8 to 99.1% for DOM1h-131-206 and relative potency in an Receptor Binding Assay had decreased by 46.5% for DOM1h-131-511 but only 24.5% for DOM1h-131-206. Finally, a nebulization study comparing DOM1h-131-511 to DOM1h-131-206 showed a 10-fold reduction in aggregate formation between the two dAbs due to thermal/shear stress after nebulization at 5 mg/ml for 3.5 min. These studies demonstrate that selecting for a lead dAb with increased protease stability has led to the identification of clones with improved storage stability, improved ability to be delivered by methods such as inhalation and potentially extended shelf life.
Comparison of alternative biophysical selection methods
In order to compare the protease selection method with thermal and low pH selection approaches, we subjected DOM1h-574-based dAb libraries to four alternative stress conditions followed by capture on antigen.
(i) Incubation at moderately high temperatures (50-65°C) for 2-16 h to select for dAbs with improved kinetic stability. (ii) Full denaturation at 80°C for 10 min to identify reversibly unfolding clones. (iii) Trypsin digest using 10-100 μg/ml trypsin for 1-37 h at 37°C. (iv) Low pH (3.2) induced denaturation for 0.5-16 h.
Enrichment of more stable clones was suggested by an increase in phage titer from 10 5 to 10 7 after the first round of stress selection to 10 7 -10 9 in later rounds. After two to three rounds of selection, the dAb sequences were PCR amplified from phage display vectors and cloned into a soluble expression vector for purification and biophysical characterization by SEC-MALLS, apparent melting temperature T m , protease resistance and target binding activity. As shown in Table IV , all four methods yielded populations that carried both Table I . 
Improvement of domain antibody biophysical properties
unique and shared mutations, mostly found in dAb CDRs, where F30S dominated in CDR1 and V104E with V104A in CDR3. The sequences, biochemical and biophysical properties for the lead dAb(s) isolated from the stress selections are summarized in Table V . Clones with improved aggregation resistance compared with the parent clone, as judged by the size of the residual soluble fraction after 47 h-incubation at 40°C, were isolated, frequently accompanied by an increase in apparent melting temperature T m , although none of the clones had become reversibly folding.
The most significant contribution to improving dAb stability was provided by mutations which introduced negatively charged amino acids into the protein sequence, F30D in CDR1 and V104E in CDR3. These mutations both increase the apparent T m for the thermal Parental clones are in italics and lead dAbs are in bold. Parental clones are in italics and lead dAbs are in bold.
unfolding of the molecule (∼5°) and improve aggregation resistance at elevated temperatures. The monomer-dimer equilibrium status of the dAbs in PBS was established by SEC-MALLS. It was found that whereas DOM1h-574-156 parent dAb is 100% monomeric at 1 mg/ml in PBS, one lead, the DOM1h-574-191 clone is predominantly dimeric. The DOM1h-574-191 clone contains an F30S mutation in CDR1 which contributes towards improved stability in proteolysis assay and residual soluble fraction following incubation at elevated temperature, but also result in dimer formation, an undesirable feature for drug development purposes. Interestingly, dAb dimer formation caused by the F30S mutation in CDR1 can be partially reversed by the presence of V104E mutation in CDR3 (clone 80% monomer) indicating that introduction of negative charge in this position can restabilize the monomeric state of the protein, while V104A mutation promotes dimer formation.
Discussion
Good biophysical properties, e.g. thermal stability and aggregation resistance, are required features of protein therapeutics in order to extend their shelf life and diminish the risk of development of antidrug antibodies in patients (Ratanji et al., 2014) . In the case of dAbs based on human frameworks it has been found that while those derived directly from whole mAbs are frequently prone to aggregation, with solubility predominantly linked to the amino acids residing at the former V H -V L interface, some germline families of such as V H 3 and V K 1, yield more stable clones (Ewert et al., 2003b) .
Attempts have been made to improve the biophysical properties of highly aggregating human V H domains by the introduction of the 'tetrad' of amino acid mutations found in the former V H -V L interface region of camelid V H H domains with the aim of reducing hydrophobicity and improving protein solubility. This approach was however only partially successful, with improvements in solubility achieved at the expense of protein expression yields and thermodynamic stability (Riechmann and Muyldermans, 1999) . At the same time, it has also been demonstrated that framework residues far removed from the interface region (Vincke et al., 2009) , as well amino acids in the CDRs, can profoundly affect the biophysical properties of dAbs like T m and refolding following thermal denaturation (Jespers et al., 2004) . Different approaches (mainly focused on V H rather than V K domains) have attempted to identify the amino acid residues/sequence motifs that are responsible for the favorable biophysical properties of these well behaved human single domains and have included replacement of exposed hydrophobic residues with more hydrophilic residues on the former light chain interface (Barthelemy et al., 2008) , the insertion of charged residues at the N-and C-terminus of a hydrophobic V H CDR3 and the insertion of charged residues at particular positions within the CDR1 of V H and CDR2 of V K domains (Dudgeon et al., 2012) . From a drug discovery perspective, CDR-located point mutations are the favored option in order to avoid the risk of introducing immunogenic determinants into the framework regions of dAbs as long as these can be accommodated without significant loss of antigen binding.
Different methods of 'stress' selection favor the selection of different characteristics, although they all promote the selections of antibodies with good biophysical properties such as resistance to aggregation, high apparent T m and ability to refold after denaturation. It has previously been noted that selection for reduced aggregation by heat selection where the dAbs undergo full denaturation did not necessarily yield clones with improved thermodynamic stability (Jespers et al., 2004) whereby in comparison partial denaturation of the dAb through acidic pH or heating to just below the melting temperature favored the selection of dAbs with improved thermodynamic stability (Famm et al., 2008) .
To investigate this further, in this study, we used protease selections with the aim to identify both V H and V K dAbs with improved biophysical properties and then compared this method with Table IV . % Frequency and mutations observed at the most commonly mutated amino acids across all clones sequenced for each selection condition Round 3  CDR1  FR2  CDR2  FR3  CDR3   F30D  F30S  K31E  V37I  L45P  S63A  G66D  I70N  I98V  V104E Residue numbering is according to Kabat. In italics are stress condition-specific mutations and in bold those identified from at least two approaches. Clone DOM1h-574-188 was selected for improved kinetic resistance to thermal inactivation at 65°C, DOM1h-574-208 for better refolding at 80°C, and and for refolding after acid denaturation at pH 3.2. The output from the trypsin selection was found to be dominated by a V104A mutation that results in dAb dimerization. Parental clones are in italics and lead dAbs are in bold.
alternative stress condition selections on a repertoire of clones derived from a single V H dAb. Resistance to cleavage by proteases has long been associated with increased conformational stability (Sieber et al., 1998) as in the native folded state, a protein is much more resistant to cleavage than in unfolded state. We therefore reasoned that the inclusion of trypsin into the phage selections would promote the selection of dAbs with increased conformational stability and indeed in the majority of our protease selections, leads were identified with increased conformational stability as measured by an increase in T m . However in line with the outcome of previous studies, these stress selection conditions did not identify clones with the ability to refold after full denaturation.
Many of the beneficial mutations identified during protease selections, which resulted in improved thermodynamic stability of dAbs, were neither related to the known protease cleavage sites nor selected for higher order multimers such as dimers. For example, enrichment of clones with mutated trypsin cleavage sites was not generally observed with the exception of mutations at a known protease cleavage site R106 in Vκ dAbs into glycine, glutamine or tryptophan (where cleavage will remove the dAb from the phage and prevent binding to antigen), which suggests the more common route to protease resistance is through the adoption of a more stable conformation, as suggested by higher apparent T m , rather than simply removing protease cleavage sites. This is confirmed by increased resistance to proteolytic digestion with other protease such as leucozyme and elastase. Indeed, mutations that remove trypsin cleavage sites could have a negative effect on protein stability, since the positive charge carried by lysines and arginines can be crucial to the maintenance of solubility and can contribute to protein resistance to aggregation after thermal denaturation (Miklos et al., 2012) .
When the four different stress conditions applied to the DOM1h-574-derived clones were compared, some mutations were more frequently present in all selected clones irresepective of the stress condition applied, while others appeared more protocol-specific. One of these common mutations (F30S) led to dAb stabilization through stable dimer formation, including V104A present in one of the parent variants, whereas others resulted in additional negative charge. The latter relates to a more generally observed mechanism whereby lower pI contributes to improved stability (Dudgeon et al., 2009; Jespers et al., 2004; , potentially through the mechanism of electrostatic repulsion disrupting self-association of hydrophobic patches. The greatest effects have been seen through the introduction of negatively charged aspartate and glutamate (Dudgeon et al., 2009; and this mirrored the effects seen in both the DOM1h-574-156 lineage where F30D and V104E dominated the outputs and in the DOM1h-131-511 lineage where the dominant mutation was V54D. In the case of DOM1h-574-156, the calculated pI would be lowered from 8.65 to 8.17 and for DOM1h-131-511, the pI would be lowered from 7.4 to 6.77.
In summary, we conclude that the use of an evolutionary approach with different selective pressures is useful for identifying dAbs with improved biophysical properties as the beneficial effect of individual mutations identified by ourselves and others are frequently context specific, dependent on both the framework and the amino acid composition of the CDRs. The use of large diversified libraries allows exploration of a broad area of sequence space enabling the identification of dAb variants with the desired biophysical characteristics. Many of the identified beneficial mutations were located within the CDR regions of the dAbs, potentially due to the destabilizing effects of introducing mutations into the conserved framework regions. Their identification indicates that there often is sufficient flexibility within the CDR sequence to allow mining for clones with improved biophysical properties without any significant impact on antigen binding activity or the potential for increased immunogenicity. In previous studies and from our own observations, these improvements in thermostability and aggregation resistance often go hand in hand with properties such as reduced interactions with column matrices and improved storage stability and therefore positively impact the ability to manufacture and formulate dAbs at the concentrations needed for successful therapeutic application.
